Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Gerald Hsu

Lymphoma · UCSF

View

Dr. Chadi Nabhan

Lymphoma · Ryght AI / USC

View

Dr. Mark Roschewski

Lymphoma · MSK

View

Dr. Jonathan Friedberg

Lymphoma · URMC

View

Dr. Matthew Matasar

Lymphoma · Rutgers Cancer Institute

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    GJDr. Gaston Jean-Louis

    Dr. Gaston Jean-Louis

    Hematology & Oncology · Lymphoma
    Columbia University Irving Medical Center
    gaston
    New York, NY

    Research

    Leveraging quality improvement principles to reduce steroid-induced hyperglycemia rates on an inpatient lymphoma service

    2026

    Via JCO Oncology Practice

    Research

    Implementing a standardized anticoagulation protocol to reduce catheter-related thrombosis (CRT) on an inpatient lymphoma service

    2026

    Via JCO Oncology Practice

    Research

    TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers

    2026

    Via European Journal of Haematology

    Research

    Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study

    2026

    Via Blood Cancer Journal

    Research

    Treatment intensity, illness burden, and disparities in newly diagnosed diffuse large B-cell lymphoma treated at an urban academic center

    2026

    Via Leukemia & Lymphoma

    Research

    Measurable Residual Disease Testing During Treatment with Bispecific Antibodies for Lymphoma

    2025

    Via Cancers (Basel)

    Research

    Organ-specific toxicity of romidepsin in patients with preexisting cardiovascular disease: a retrospective analysis

    2022

    Via Leukemia & Lymphoma